⌘K

Login Start Free

Home/Filings/4/0001209191-21-043137

4//SEC Filing

Hassard James 4

Accession 0001209191-21-043137

CIK 0000879407other

View on SEC.gov Company Profile

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 6:44 PM ET

Size

5.0 KB

Accession

0001209191-21-043137

Insider Transaction Report

Form 4

Period: 2021-06-22

ARROWHEAD PHARMACEUTICALS, INC.ARWR

Chief Commercial Officer

Transactions

Sale
Common Stock
2021-06-22$89.22/sh−3,625$323,423→ 105,750 total

Footnotes (1)

[F1]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ARROWHEAD PHARMACEUTICALS, INC.

CIK 0000879407

Entity typeother

Related Parties

1

filerCIK 0001799357

Filing Metadata

Form type: 4
Filed: Jun 23, 8:00 PM ET
Accepted: Jun 24, 6:44 PM ET
Size: 5.0 KB

View on SEC.gov